Biospringer by Lesaffre expands into bacterial fermentation with PTX Food Technology acquisition
The acquisition aims to accelerate Biospringer’s growth in the food ingredients market, unlocking new opportunities beyond yeast fermentation.
FRANCE – Biospringer by Lesaffre, a dominant global business unit specializing in food fermentation, has officially announced the acquisition of selected intellectual property (IP) and technology assets from United States-based bacteria fermentation specialist PTX Food Corp.
This tactical transaction represents a structural category expansion for the company, marking its first major technological pivot beyond its centuries-old yeast fermentation portfolio into advanced non-yeast-fermented ingredient solutions.
The center vertical of the transaction is the strategic acquisition of selected technology and intellectual property assets linked directly to PTX Food Corp’s flagship Bioenhance product line.
Established in the United States in 1972, PTX Food Corp has built a strong reputation within the North American food sector as a specialized manufacturer of bacteria-fermented ingredients used extensively for clean-label flavor development, natural biopreservation, and advanced texturizing solutions.
By absorbing these specialized capabilities, Biospringer is positioning itself to capture a larger share of the fast-growing clean-label, functional taste, and natural preservation markets.
To capitalize immediately on these newly acquired assets, Biospringer is executing a rapid global technology-transfer program.
The biotechnology group plans to transfer and integrate the proprietary manufacturing equipment and intellectual processes from PTX Food’s facilities directly into Biospringer’s existing international production network, which currently spans operations across Europe, Brazil, China, and North America.
This multi-regional industrial integration will allow the business unit to scale a previously boutique North American product line into a high-volume global ingredient, while providing business-to-business (B2B) food manufacturing clients with regional sourcing security closer to primary consumption hubs.
In a mature global food ingredients market, major food and beverage brands face intense pressure from retail consumers and health regulators to formulate products with minimal synthetic additives.
While yeast extracts have long served as the default natural tool for taste modulation and sodium reduction, the integration of bacterial fermentation opens up entirely new biochemical pathways for food science formulators.
Carmen Arruda, General Manager of Biospringer, characterized the corporate acquisition as fully aligned with the company’s long-term commitment to delivering game-changing biotech platforms.
Arruda emphasized that by combining legacy ingredient innovation with multi-organism biotechnology platforms, Biospringer is uniquely poised to transition from a specialized yeast producer into a highly versatile fermentation ecosystem, solidifying its role as a trusted partner in the global pursuit of clean-label and sustainable nourishment.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
